| Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, ... Proceedings of the National Academy of Sciences 104 (41), 16170-16175, 2007 | 685 | 2007 |
| The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ... The EMBO journal 30 (13), 2719-2733, 2011 | 657 | 2011 |
| Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ... Cancer research 67 (10), 5033-5041, 2007 | 604 | 2007 |
| Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer P Rocchi, A So, S Kojima, M Signaevsky, E Beraldi, L Fazli, ... Cancer research 64 (18), 6595-6602, 2004 | 374 | 2004 |
| Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance H Tanaka, E Kono, CP Tran, H Miyazaki, J Yamashiro, T Shimomura, ... Nature medicine 16 (12), 1414-1420, 2010 | 364 | 2010 |
| High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug DevelopmentNext-Generation Models of Prostate Cancer D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ... Cancer research 74 (4), 1272-1283, 2014 | 359 | 2014 |
| Regulation of tumor angiogenesis by integrin-linked kinase (ILK) C Tan, S Cruet-Hennequart, A Troussard, L Fazli, P Costello, K Sutton, ... Cancer cell 5 (1), 79-90, 2004 | 337 | 2004 |
| A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer KN Chi, E Eisenhauer, L Fazli, EC Jones, SL Goldenberg, J Powers, D Tu, ... Journal of the National Cancer Institute 97 (17), 1287-1296, 2005 | 316 | 2005 |
| Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development Q Wang, RA Hardie, AJ Hoy, M Van Geldermalsen, D Gao, L Fazli, ... The Journal of pathology 236 (3), 278-289, 2015 | 302 | 2015 |
| Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity A Zoubeidi, A Zardan, E Beraldi, L Fazli, R Sowery, P Rennie, C Nelson, ... Cancer research 67 (21), 10455-10465, 2007 | 290 | 2007 |
| The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerBRN2 Is an AR-Suppressed Driver of NEPC JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ... Cancer discovery 7 (1), 54-71, 2017 | 284* | 2017 |
| Increased hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3–mediated … P Rocchi, E Beraldi, S Ettinger, L Fazli, RL Vessella, C Nelson, M Gleave Cancer research 65 (23), 11083-11093, 2005 | 257 | 2005 |
| Insulin receptor expression by human prostate cancers ME Cox, ME Gleave, M Zakikhani, RH Bell, E Piura, E Vickers, ... The Prostate 69 (1), 33-40, 2009 | 244 | 2009 |
| The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells Y Xie, K Xu, DE Linn, X Yang, Z Guo, H Shimelis, T Nakanishi, DD Ross, ... Journal of Biological Chemistry 283 (6), 3349-3356, 2008 | 231 | 2008 |
| Frequency of the TMPRSS2: ERG gene fusion is increased in moderate to poorly differentiated prostate cancers AB Rajput, MA Miller, A De Luca, N Boyd, S Leung, A Hurtado-Coll, ... Journal of clinical pathology 60 (11), 1238-1243, 2007 | 231 | 2007 |
| The placental gene PEG10 promotes progression of neuroendocrine prostate cancer S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ... Cell reports 12 (6), 922-936, 2015 | 224 | 2015 |
| Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate CancerRole of Hsp27 in EMT and Prostate Cancer Metastasis M Shiota, JL Bishop, KM Nip, A Zardan, A Takeuchi, T Cordonnier, ... Cancer research 73 (10), 3109-3119, 2013 | 214 | 2013 |
| Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model SL Krueckl, RA Sikes, NM Edlund, RH Bell, A Hurtado-Coll, L Fazli, ... Cancer research 64 (23), 8620-8629, 2004 | 205 | 2004 |
| Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer LM FitzGerald, I Agalliu, K Johnson, MA Miller, EM Kwon, A Hurtado-Coll, ... BMC cancer 8, 1-10, 2008 | 200 | 2008 |
| Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development Q Wang, J Tiffen, CG Bailey, ML Lehman, W Ritchie, L Fazli, C Metierre, ... Journal of the National Cancer Institute 105 (19), 1463-1473, 2013 | 199 | 2013 |
Pooyan FazliArizona State UniversityVerified email at asu.edu
